November 7, 2009
Abuse, Antidepressants, Antipsychotic, Big Pharma, Fraud, GlaxoSmithkline, News, Paxil, Psychiatrist
No Comments
BY JOHN DORSCHNER
jdorschner@MiamiHerald.com
Charles Nemeroff, an Atlanta psychiatrist who was the subject of a Senate investigation concerning huge sums he received from drug companies, has been named chairman of the psychiatry department at the University of Miami.
Last year Nemeroff, as the top psychiatrist at Emory University, was the focus of an investigation by Sen. Charles Grassley, R-Iowa, who said he was concerned about the millions the psychiatrist received from drug companies while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from.
On Thursday, Pascal Goldschmidt, dean of UM medical school, called Nemeroff “an exceptional psychiatrist and an exceptional scientist who has one issue in which he recognizes he made a mistake,” in not telling Emory how much he was getting from drug makers.
Goldschmidt said he had read investigative reports from Emory about Nemeroff’s activities and Emory found nothing to indicate that payments the psychiatrist received had in any way influenced his research results.
Read the rest…
January 16, 2009
Antidepressants, Big Pharma, DSM, Eli Lilly, FDA, Fraud, GlaxoSmithkline, News, Paxil, Pfizer, Prozac, Psychiatry, Psychotropic drugs, Videos, Wyeth, Zoloft, effexor, unhappy patients
No Comments
Addiction, violence and suicide – these are some of the thousands of risks of antidepressants, but you won’t hear about it from your doctor, because he doesn’t know.
Paxil, Zoloft, Effexor, Prozac – how effective are they? Does Big Pharma want you to know? Douglas Kennedy – Fox News.
The risk of suicide at least doubles for children taking antidepressants according to short-term clinical trials.
Antidepressants are compared by researchers to cocaine in the DSM lll.
December 20, 2008
Antidepressants, Antipsychotic, Big Pharma, Fraud, GlaxoSmithkline, News, Paxil, Psychiatrist, Psychiatry, Psychotropic drugs
No Comments
By GAYLE WHITE |The Atlanta Journal-Constitution
Thursday, December 18, 2008
In a stern letter to Emory University this week, U.S. Sen. Charles Grassley questions whether renowned psychiatrist Dr. Charles Nemeroff has honestly portrayed some of his activities funded by pharmaceutical companies.
Grassley warns school officials of the potential penalties for making false statements or obstructing a congressional examination.
Nemeroff, an internationally known expert on depression, has become a central figure in an investigation this year by the Senate Finance Committee into whether drug company money paid to physicians compromises medical research and scholarship. Grassley (R-Iowa) is the ranking minority member of the committee.
Grassley’s letter, obtained by The Atlanta Journal-Constitution, questions Emory’s position that some talks by Nemeroff funded by the pharmaceutical company GlaxoSmithKline were educational and did not involve promotion of Glaxo products.
Read the rest…
